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Abstract
Mice are commonly used as an experimental model to investigate the Equid herpesvirus 1 (EHV-1) infection. This model easily
reproduces the disease, and the clinical signs are more or less similar to those observed in the horse, the natural host. During
natural infection, the acute course of respiratory infection is mandatory for the development of adaptive immune response. Since
interactions between EHV-1 and anesthetics are possible, the study investigated whether the early events of murine pulmonary
immune response could be affected by different anesthetics. Therefore, mice were experimentally infected with a unique EHV-1
strain under the effects of ether, ketamine/xylazine, or isoflurane. Clinical signs and histopathological lesions in the lungs were
described, and the cell death and proliferation rates of sham-inoculated or infected animals were quantified using immunohisto-
chemistry. Clinical signs were more severe in animals anesthetized with ether. Qualitative differences in the recruited inflamma-
tory cells were observed following application of anesthesia. The level of infection among the infected groups was not statistically
significant. However, lungs from ketamine/xylazine-anesthetized animals showed the highest cell death rates, whereas those from
isoflurane-anesthetized animals showed the highest proliferation rates. It has been emphasized that anesthetics alone or their
interactions with EHV-1 modify the response against the infection. An appropriate selection of the anesthetic during experimental
studies is relevant to minimize wrong conclusions.
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The family Herpesviridae includes a large number of viruses
that infect a wide range of hosts. Equid herpesvirus (EHV-1)
is a varicellovirus belonging to the subfamily Alphaherpesvir-
inae and causes a worldwide epidemic of abortion, perinatal
mortality, respiratory disease, and neurological disorders in
horses.19 EHV-1 enters the host through the respiratory airways
and causes respiratory disease. The virus has the ability to
remain latent in lymphoid cells and neurons of the trigeminal
ganglia.17,23 Reactivation frequently occurs under immune
depression.10 A leukocyte-associated viremia allows the virus
to reach the uterus and the central nervous system, causing
reproductive and neurological disorders.30 Primary and reacti-
vated herpesvirus infections can be asymptomatic or result in
diseases of variable severity.2
Awan et al4 used a murine model to induce EHV-1 infec-
tion, allowing a better understanding of different virological,
histopathological, and immunological aspects of the disease.28
In this study, animals were intranasally inoculated with
infected cell culture medium under a light anesthesia. The
anesthesia is used to reduce the animal’s suffering and the pos-
sible expulsion of the inoculum that may reduce the effective-
ness of the infection. In the model proposed by Awan et al,4
ether was used extensively in many experiences. However,
because of the irritant properties to mucous membranes,
especially those of the respiratory tract, and the significant risk
of fire or explosion, this popular anesthetic was replaced by
ketamine/xylazine13 or by isoflurane.14 Several studies have
suggested that anesthetics may alter tissue homeostasis.5,9,25
So far, the possible effects of such anesthetics on EHV-1 infec-
tion have not been investigated.
Therefore, the aim of this work was to study possible
differences in clinical signs, histopathological lesions, cell
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proliferation, and death rates in sham-inoculated and infected
mice under the effects of 3 anesthetics.
Material and Methods
Experimental Design
To explore the effects of ether in the murine model, sections
of paraffin-embedded lungs from a previous experiment were
studied. One of the researchers of our group actively partici-
pated in the experimental proceeding of that assay
(C.M.G.). In that experiment, 10 specific pathogen–free
BALB/c male mice that were 6 weeks old were anesthetized
with ether and intranasally inoculated with EHV-1 (AR4
strain) or sham-inoculated. All the experimental conditions
were rigorously registered.
Two groups of 10 mice each were anesthetized with keta-
mine/xylazine and isoflurane, respectively; then 5 animals of
each of these groups were intranasally inoculated with AR4
EHV-1 strain and the other 5 were sham-inoculated. All the
animals shared the same age, strain, and gender and had the same
microbiological status. Two days post inoculation, mice were
anesthetized with the same anesthetics selected for the inocula-
tion and then were killed by exsanguination. Volatile com-
pounds including ether (Merck, Darmstadt, Germany) and
isoflurane (Baxter Co., Deerfield, IL) were dispensed in a closed
chamber until animal were unconscious. Ketamine (Ketamina,
Laboratorios Holiday, Buenos Aires, Argentina) (drug dose 50
mg/kg) and xylazine (Xilacina clorhidrato; Laboratorios Ritch-
mond, Buenos Aires, Argentina) (drug dose 10 mg/kg) were
intraperitoneally administered.
Virus Strain and Intranasal Inoculation
The abortigenic EHV-1 strain (AR4) was isolated in Argentina
from a foal that died 24 hours after birth.20 After 4 passages in
RK13 cells (rabbit kidney), a viral stock was prepared, titrated
by standard Reed and Muench method, and stored at –70C in
liquid nitrogen. Aliquots of this viral strain stock were propa-
gated in RK13 cells and used in both assays. Cell cultures were
allowed to grow with a minimal essential medium supplemen-
ted with 10% fetal calf serum and titrated as previously
described.12 Fifty microliters of supernatant (105.75 CCID50/
50 ml) or 50 ml of virus-free cell culture was intranasally inocu-
lated in the animals of both experiments.12
Clinical Assessment
Mice were examined at the beginning and at the end of the
experiment. Clinical signs were recorded as highly severe,
severe, or mild by the same operator in both experiments
(C.M.G.). The current proceedings were revised and approved
by the Institutional Animal Care and Use Committee of the
Faculty of Veterinary Sciences of La Plata National University
and were performed in accordance with the Guide for the Care
and Use of Laboratory Animals of the National Research
Council.
Histopathological Analysis
Tissue processing and histopathological analysis. Lungs were
fixed in 10% buffered formaldehyde (pH 7.4) for 12 hours and
then dehydrated, clarified, and embedded in paraffin wax.
Paraffin-embedded sections (3 mm thick) were stained with
hematoxylin and eosin (HE). Morphological descriptions were
conducted by 2 independent researchers (M.L.E., C.N.Z.).
Immunohistochemistry. The magnitude of the infection and
the proliferation and death rates in the sites of infection by
EHV-1 were studied using immunohistochemistry to detect
EHV-1 antigen proliferating cell nuclear antigen (PCNA) and
caspase 3 antigen, respectively.
Sections (3 mm thick) were mounted on positively charged
slides (Biotraza microscope slides, Cat. #HDAS001A, Huida
Medical Instruments Co., Jiangsu, China), deparaffinized, dehy-
drated, incubated with 3% H2O2 in methanol for 30 minutes at
room temperature, and rinsed in phosphate-buffered saline (PBS,
pH 7.4). Antigen retrieval was applied using 750 W of micro-
wave irradiation twice for 5 minutes in citrate buffer (pH 6.0).
Nonspecific binding sites were blocked with 2% bovine serum
albumin (BSA) þ 5% skim milk (for EHV-1 antigen) or 1%
BSA (for PCNA and caspase 3 antigens) for 30 minutes in a
humid chamber at 4C, followed by the primary antibody incu-
bation for 1 hour at 37C. Liquid 3,3-diaminobenzidine tetrahy-
drochloride (DAB) was used as chromogen (DakoCytomation,
Glostrup, Denmark), and Hill’s hematoxylin was used for
counterstaining.33
Detection of EHV-1 antigen. A polyclonal anti-EHV-1 rabbit
serum produced in our laboratory was used as primary antibody
(1/1500 dilution). Slides were incubated for 1 hour at 37C,
rinsed in PBS 3 times for 5 minutes each, and incubated with
anti-rabbit EnVision detection systemþHRP (DakoCytoma-
tion) for 30 minutes at room temperature. Then sections were
rinsed in PBS, revealed, and counterstained. In each slide, a
section of a positive infected sample was included. As a nega-
tive control, the primary antibody was replaced with a normal
rabbit serum.33
Proliferation assessment. Mouse monoclonal anti-PCNA was
used as a primary antibody (clone PC 10, ascites fluid, Sigma
Chemical Co., St. Louis, MO, EE.UU, 1/3000 dilution). The
primary antibody was pretreated with Dako ARK (Animal
Research Kit) Peroxidase System (code K3954) to reduce the
possible reactivity of the detection system with endogenous
immunoglobulin. Nonspecific binding sites of endogenous bio-
tin were blocked with an avidin-biotin blocking kit (Cat.
#HK102-5K, Biogenex, Fremont, CA). The antibody-Dako
ARK polylinker complex was then incubated for 1 hour at
37C, rinsed in PBS 3 times for 5 minutes each, revealed, and
counterstained.33
Apoptosis assessment. The sections were incubated with rab-
bit anti-caspase 3 (active form) polyclonal antibody (1/50 dilu-
tion) (Cat. #AB3623 Chemicon International, Inc., Temecula,
CA) overnight at 4C. Anti-rabbit EnVision detection
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Figure 1. Lung, mice. Sham-inoculated (control) animal. No histopathological lesions were found in lungs from sham-inoculated animals
anesthetized with ketamine/xylazine. HE. Figure 2. Lung, mice. Interalveolar walls appeared slightly thickened in lungs from sham-
inoculated animals anesthetized with isoflurane. HE. Figure 3. Lung, mice. Mild peribronchial inflammatory reaction in lungs from sham-
inoculated animals anesthetized with ether. Note the accumulation of cells, mostly neutrophils and monocytes, in the bronchiolar lumen
(arrows). HE. Inset: Higher magnification to distinguish neutrophils and monocytes. Figure 4. Lung, mice. Severe inflammatory changes
in lungs from EHV-1-infected animals anesthetized with ether. Epithelial erosion, peribronchiolar neutrophilic and lymphocytic infiltration,
and moderate neutrophilic accumulation (arrow) in the bronchiolar lumen. HE. Figure 5. Lung, mice. Lymphocytic infiltration around
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systemþHRP (DakoCytomation) was then used for 30 minutes
at room temperature. Sections were then rinsed in PBS twice
for 5 minutes, treated with DAB, and counterstained.
Infection, Cell Proliferation, and Cell Death Quantification
The quantification of these parameters was performed by
digital image analysis with the program Image-Pro Plus 6.0
(MediaCybernetics, Bethesda, MD). A total of 20 digital
images (40 magnification) for each animal were captured.
The areas of bronchus/bronchiole were manually selected, and
the ratio of immunostained tissue for EHV-1 antigen versus
total selected area was measured. PCNA and caspase 3 immu-
nostained cells were counted. A set of pixels were defined as
immunostained tissue, and the clusters of pixels, whose
size was in accordance with nucleus (PCNA) or cell size
(caspase 3), were counted.
Antigen stability was tested comparing the staining intensity
of tissue samples (archival and current samples) with the same
positive control.
Statistical Analysis
To compare mean values in the infection ratio, 1-way analysis
of variance (ANOVA) was performed followed by multiple
comparisons Tukey test to compare mean values of infection.
When proliferation rates were compared, interactions between
anesthetic and infection were studied using 2-way ANOVA and
Tukey test, after logarithmic data transformation. Homoscedas-
ticity was evaluated using the Levene test. Because of the non-
homoscedastic nature of caspase 3 data distributions,
nonparametric tests were performed. Mann-Whitney test was
performed to compare the mean value of sham-inoculated
groups versus infected groups for each anesthetized animal.
Kruskal-Wallis test was used to compare the anesthetics effects
within sham-inoculated and infected groups. The validation of
antigen stability was analyzed using Dunnett multiple compar-
isons test.
Results
Clinical Signs
Three sham-inoculated animals anesthetized with ether showed
mild or severe dyspnea 24 hours post inoculation, whereas no
clinical signs were observed in the other 2 sham-inoculated ani-
mals. All infected mice showed depression, dyspnea, tachyp-
nea, ruffled fur, and hunched posture. These signs were mild
in the groups anesthetized with ketamine/xylazine or isoflur-
ane, and they were highly severe in the infected mice anesthe-
tized with ether.
Histopathological Findings
No histological evidence of infection was observed in the lungs
of sham-inoculated mice anesthetized with ketamine/xylazine
(Fig. 1) or isoflurane, although the lungs from the latter showed
slightly thickened interalveolar walls (Fig. 2). Mild inflamma-
tory reactions were found in the lungs from sham-inoculated
mice anesthetized with ether. In such animals, lymphocytic and
neutrophilic infiltration was observed around bronchi, bronch-
ioles, and blood vessels. Furthermore, interalveolar walls
appeared thickened, and erosion foci were present in bronchial
and bronchiolar epithelia (Fig. 3).
Lungs of all infected mice showed typical foci of EHV-1
infection in bronchial and bronchiolar epithelia, including
desquamation, syncytia, and epithelial cells with eosinophilic
intranuclear inclusion bodies. Although the morphological
changes induced by EHV-1 infection were similar in all
groups, recruited inflammatory cells were qualitatively var-
ied. Lungs of infected mice anesthetized with ether showed
severe neutrophilic infiltration and, to a lesser extent, mono-
cytes in the bronchiolar lumen and lymphocytes surrounding
bronchioles and blood vessels (Fig. 4). In the lungs of infected
mice anesthetized with ketamine/xylazine (Fig. 5) or isoflur-
ane (Fig. 6), there was thickening of alveolar walls and lym-
phocytic infiltration surrounding respiratory airways and
blood vessels.
Immunohistochemistry
No statistically significant difference was found in the intensity
of EHV-1, PCNA, or caspase 3 immunostaining in all infected
animals.
EHV-1 Antigen. EHV-1 immune reactivity was found in
bronchial and bronchiolar epithelia and in some alveolar cells
in lungs of infected mice (Fig. 7). The level of infection
between the infected groups was not statistically significant
(P > .09; ANOVA) (Fig. 10).
Cell proliferation. Lungs from all animals showed the same
antigenic distribution pattern. The PCNA-stained nuclei were
predominantly found in the epithelium, in some instances, and
in some detached cells of the bronchial lumen. Furthermore,
some alveolar infected cells were positively stained (Fig. 8).
The number of PCNA-positive cells increased in all the
infected groups with respect to sham-inoculated groups.
Between the infected groups, the number of PCNA-positive
cells significantly increased in mice anesthetized with isoflur-
ane, whereas no significant difference was found between
sham-inoculated groups (Fig. 11).
Cell death. The number of caspase 3–positive cells in the
lungs of infected animals increased with respect to sham-
Figure 1. (Continued) airways and vessels in the lung from an EHV-1-infected animal anesthetized with ketamine/xylazine. HE. Figure 6.
Lymphocytic infiltration around airways and vessels in the lung from an infected animal anesthetized with isoflurane. There is detachment of
bronchial and bronchiolar epithelium, indicative of infection with EHV-1 (arrow head) and syncytia (arrow). HE. Inset: Higher magnification of
the syncytia cell.
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Figure 7. Lung, mice. Immunochemical labeling for EHV-1 antigen at the bronchiolar epithelial cells from an infected animal anesthetized with
ketamine/xylazine. Diaminobenzidine chromogen, hematoxylin counterstain. Figure 8. Lung, mice. Proliferating cell detection. Positive
PCNA-immunostained nuclei localized in bronchiolar epithelium in the lung of an infected animal anesthetized with isoflurane. Diaminoben-
zidine chromogen, hematoxylin counterstain. Figure 9. Lung, mice. Apoptotic cell detection. Scarce cells positive to caspase 3 antigen
(arrows) localized surrounding an infectious focus in a bronchiole from an animal anesthetized with ketamine/xylazine. Diaminobenzidine
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inoculated animals for all the anesthetics, although this
increase was not significant for ether. The highest number of
immunostained cells was observed in the lungs of infected ani-
mals anesthetized with ketamine/xylazine (P < .05, Kruskal-
Wallis test; Fig. 12). The distribution pattern of caspase 3–pos-
itive immunostained cells was found surrounding the infection
foci and not within them (Fig. 9).
Discussion
In this work we used a murine model of EHV-1 infection under
the effect of 3 different anesthetics to study the clinical signs,
histopathological lesions, and cell proliferation and death rates
in the lungs. Infected animals anesthetized with ether showed
the most severe clinical signs and histopathological lesions.
However, no relationship was observed between the intensity
of the histopathological lesions and the level of infection deter-
mined by immunohistochemistry, since sham-inoculated ani-
mals anesthetized with ether also showed dyspnea after
inoculation. The infected animals anesthetized with keta-
mine/xylazine or isoflurane showed mild clinical signs, less
intense histopathological lesions, and a higher infection level
(although it was not statistically significant). The dyspnea
found in animals anesthetized with ether may be more related
to the impairment in ventilation caused by the inflammatory
changes and the increased thickness of interalveolar walls than
to the epithelial loss itself. Other researchers reported that mice
infected with influenza virus showed extended pneumonia after
ether anesthesia in comparison with other anesthetics.16 The
great number of neutrophils found in lungs of animals anesthe-
tized with ether disagrees with the fact that glycoprotein G (gG)
of EHV-1 has the ability to impair neutrophil and monocyte
recruitment to the infection foci.26 Moreover, gG binds to dif-
ferent chemokines, like murine CCL3,6 and the interaction
between these chemokines and gG is mandatory during the pri-
mary EHV-1 infection.27 These findings were obtained using
isoflurane in vitro and in vivo.26 Despite the fact that EHV-1
is able to inhibit neutrophil chemotaxis, we suggest that ether
may block or overtake the effect of gG, since in sham-
inoculated and infected animals there was a great neutrophilic
infiltration.
Ether increases vascular permeability and produces necrosis
and irritation of the respiratory airways.15 As a result, certain
molecules are released and activate Toll like-receptor (TLR)
2 and 4.11 EHV-1 could also activate TLR 2, 3, 7, and 9.22,31
The pattern of TLR activation is critical to define the innate and
adaptive immune response profile.1 It could be suggested that
activation of TLRs by damage associated molecular pattern
molecules and by EHV-1 might explain the discrepancies
found in mice anesthetized with ether. In addition, histopatho-
logical changes described in the lungs of such animals might be
related to nonspecific acute inflammatory response rather than
the well-known specific pulmonary reaction described in the
natural host.3
Despite similar histopathological changes, lungs from
infected animals anesthetized with isoflurane and ketamine/
xylazine showed different proliferation and cell death rates,
thus suggesting temporal variations in the resolution of the
infection reaction. Many studies have reported that ketamine
possesses anti-inflammatory properties.18,25 Moreover, keta-
mine impairs the release of interleukins (1b, 6, and 8) and
tumor necrosis factor alfa (TNF-a) in response to different sti-
muli7,8,24,29 and inhibits the maturation of bone marrow-
derived dendritic cells and T-helper-1 type immune response
priming.21 In a murine model of burn injury, it was shown that
ketamine increases the apoptotic rates in the intestinal epithe-
lium.32 In addition, the positive immunoreactivity for caspase
3 antigen in lungs of infected animals increased under ketamine
anesthesia. This might be explained by the proapoptotic effect
of ketamine, although the interaction between the infection and
the anesthetics could not be tested. The present study was per-
formed at a particular time of the infection (2 days post inocu-
lation) during which changes under isoflurane anesthesia may
occur sooner than those under ketamine/xylazine. As a result,
the lower cell death level and the higher proliferation rate
found in infected animals anesthetized with isoflurane may
indicate the beginning of the regeneration and recovery phase.
The present work emphasizes the relevance of an appropri-
ate selection of the anesthetic during experimental studies, par-
ticularly to study EHV-1 infection. Although many advances in
the immune response, pathogenesis, or immunogenic capacity
of EHV-1 strains have been obtained in experimental assays
using different anesthetics, such as ether and ketamine/xyla-
zine, it is clear that undesirable effects caused by the anesthesia
or a possible interaction between anesthetics and EHV-1 might
force a modified immune response against the natural infection
or experimental inoculation. These effects might also induce
different changes from those specific to the virus, and the eli-
cited response may lead to wrong outcomes.
In conclusion, the diversity of compounds used as anes-
thetics might affect the extrapolation and comparison of data
between different experimental assays used to reproduce the
EHV-1 infection in mice. Therefore, isoflurane could be con-
sidered a good anesthetic for such investigations since it pro-
duces few known side effects. Besides, animals suffer little
distress and show a better postanesthesia recovery.
Figure 7. (Continued) chromogen, hematoxylin counterstain. Figure 10. Infection ratio (ratio of immunostained tissue for EHV-1 antigen
versus total selected area) for each anesthetic. No significant differences were found when 1-way ANOVA was performed (P > .11). Figure
11. Proliferation rates for each anesthetic in sham-inoculated and infected groups. Proliferation rate significantly increased in lungs from
infected animals anesthetized with isoflurane (Tukey test P < .001). The proliferation rate was affected by the anesthetic used and by
EHV-1 infection, and no interaction between anesthetics and infection was found (2-way ANOVA: P < .001, P < .001, and P > .62, respec-
tively). Figure 12. Apoptotic rate for each anesthetic in sham-inoculated and infected groups. Significant differences were found between
sham-inoculated and infected groups anesthetized with ketamine/xylazine or isoflurane (Mann-Whitney test, P < .005 and P < .05, respec-
tively) and between infected groups (Kruskal-Wallis test, P < .05).
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